These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 11364486)

  • 41. [Drug resistance in antiretroviral therapy of HIV infection].
    Oette M; Häussinger D
    Med Klin (Munich); 2003 Dec; 98(12):692-9. PubMed ID: 14685670
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of resistance testing in clinical trial design and product labelling: a regulatory perspective.
    Laessig KA; Murray JS; Chikami G
    Antivir Ther; 2000 Mar; 5(1):77-83. PubMed ID: 10846597
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Human immunodeficiency virus resistance to antiretroviral drugs].
    Karmochkine M; Descamps D
    Ann Med Interne (Paris); 1999 Dec; 150(8):615-22. PubMed ID: 10686643
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A physician's primer to antiretroviral drug resistance testing.
    Wilson JW; Bean P
    AIDS Read; 2000 Aug; 10(8):469-73, 476-8. PubMed ID: 10967806
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antiretroviral drug resistance testing in adults with HIV infection: implications for clinical management. International AIDS Society--USA Panel.
    Hirsch MS; Conway B; D'Aquila RT; Johnson VA; Brun-Vézinet F; Clotet B; Demeter LM; Hammer SM; Jacobsen DM; Kuritzkes DR; Loveday C; Mellors JW; Vella S; Richman DD
    JAMA; 1998 Jun; 279(24):1984-91. PubMed ID: 9643863
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Principles of HIV resistance testing and overview of assay performance characteristics.
    Richman DD
    Antivir Ther; 2000 Mar; 5(1):27-31. PubMed ID: 10846590
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Individualization of therapy using viral markers.
    Merigan T
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S41-6. PubMed ID: 8595507
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HIV resistance testing: methods, utility, and limitations.
    Alcorn TM; Faruki H
    Mol Diagn; 2000 Sep; 5(3):159-68. PubMed ID: 11070150
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Drug resistance. An updated, user-friendly guide to genotype interpretation.
    MacArthur RD
    AIDS Read; 2000 Nov; 10(11):652-7. PubMed ID: 11186189
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Resistance to antiretroviral drugs.
    Calvez V
    Antivir Ther; 1998; 3 Suppl 4():5-7. PubMed ID: 10723502
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Resistance: how HIV evolves to survive.
    Colvin R
    Common Factor; 1995 Apr; (no 10):13-4. PubMed ID: 11362338
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Resistance to antiretroviral drugs.
    O'Brien W
    BETA; 1998 Jan; ():11-4, 63. PubMed ID: 11364970
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HIV resistance: a primer.
    PI Perspect; 1996 Nov; (No 20):6-7. PubMed ID: 11363971
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Follow PI doses or don't prescribe them at all, researchers say.
    AIDS Alert; 1997 Apr; 12(4):37-40. PubMed ID: 11364144
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Resistance testing: a primer for clinicians.
    Erbelding EJ
    Hopkins HIV Rep; 1999 May; 11(3):1, 8-9. PubMed ID: 11367369
    [TBL] [Abstract][Full Text] [Related]  

  • 56. When HIV breaks through.
    Cenko D
    BETA; 1997 Sep; ():14-6. PubMed ID: 11364692
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HIV resistance to antiretroviral drugs: mechanisms, genotypic and phenotypic resistance testing in clinical practice.
    Blaise P; Clevenbergh P; Vaira D; Moutschen M; Dellamonica P
    Acta Clin Belg; 2002; 57(4):191-201. PubMed ID: 12462795
    [TBL] [Abstract][Full Text] [Related]  

  • 58. International perspectives on antiretroviral resistance. Phenotypic and genotypic resistance assays: methodology, reliability, and interpretations.
    Demeter L; Haubrich R
    J Acquir Immune Defic Syndr; 2001 Mar; 26 Suppl 1():S3-9. PubMed ID: 11264997
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A simple and cost-saving phenotypic drug susceptibility testing of HIV-1.
    Weng Y; Zhang L; Huang J; Zhao J; Luo P; Bi S; Yang Z; Zhu H; Allain JP; Li C
    Sci Rep; 2016 Sep; 6():33559. PubMed ID: 27640883
    [TBL] [Abstract][Full Text] [Related]  

  • 60. International perspectives on antiretroviral resistance. Clinical utility of resistance testing: retrospective and prospective data supporting use and current recommendations.
    Haubrich R; Demeter L
    J Acquir Immune Defic Syndr; 2001 Mar; 26 Suppl 1():S51-9. PubMed ID: 11265001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.